[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism

Michele Tinazzi, Andrea Cipriani, Angela Matinella, Antonino Cannas, Paolo Solla, Alessandra Nicoletti, Mario Zappia, Letterio Morgante, Francesca Morgante, Claudio Pacchetti, Massimo Sciarretta, Carlo Dallocchio, Simone Rossi, Maria Malentacchi, Roberto Ceravolo, Daniela Frosini, Stelvio Sestini, Tommaso Bovi, Corrado Barbui

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Drug-induced parkinsonism (DIP) in patients treated with antipsychotic drugs is considered a form of post-synaptic parkinsonism, caused by D2-receptor blockade. Recent studies, however, carried out on small and heterogeneous patient samples, have shown that DIP may be associated with [123I]FP-CIT single photon emission computed tomography (SPECT) abnormalities, which are markers of dopamine nigrostriatal terminal defect.In the present study, outpatients fulfilling the DSM-IV criteria for schizophrenia and treated with antipsychotics for at least 6months, were enrolled in order to estimate the prevalence of DIP and, among patients with DIP, the prevalence of [123I]FP-CIT SPECT abnormalities. Socio-demographic and clinical variables associated with the presence of DIP and SPECT abnormalities were also assessed.DIP was diagnosed in 149 out of 448 patients with schizophrenia (33%). Age, use of long-acting antipsychotics and a positive family history of parkinsonism were the only demographic variables significantly associated with the development of DIP. Neuroimaging abnormalities were found in 41 of 97 patients who agreed to undergo [123I]FP-CIT SPECT (42%). Only age differentiated this group of patients from those with normal imaging.These preliminary findings suggest that D2-receptor blockade may coexist with a dopamine nigrostriatal terminal defect, as assessed by [123I]FP-CIT SPECT abnormalities, in a relevant proportion of DIP patients. Longitudinal studies should be designed with the aim of improving our understanding of the mechanisms of pre-synaptic abnormalities in DIP patients and identifying specific treatment strategies.

Original languageEnglish
Pages (from-to)40-45
Number of pages6
JournalSchizophrenia Research
Volume139
Issue number1-3
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Parkinsonian Disorders
Single-Photon Emission-Computed Tomography
Pharmaceutical Preparations
Antipsychotic Agents
Drug-Induced Abnormalities
Dopamine
Schizophrenia
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
Demography
Neuroimaging
Diagnostic and Statistical Manual of Mental Disorders
Longitudinal Studies
Outpatients
Age Groups

Keywords

  • [I]FP-CIT SPECT
  • Antipsychotics
  • Dopamine receptors
  • Parkinsonism
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Tinazzi, M., Cipriani, A., Matinella, A., Cannas, A., Solla, P., Nicoletti, A., ... Barbui, C. (2012). [123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. Schizophrenia Research, 139(1-3), 40-45. https://doi.org/10.1016/j.schres.2012.06.003

[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. / Tinazzi, Michele; Cipriani, Andrea; Matinella, Angela; Cannas, Antonino; Solla, Paolo; Nicoletti, Alessandra; Zappia, Mario; Morgante, Letterio; Morgante, Francesca; Pacchetti, Claudio; Sciarretta, Massimo; Dallocchio, Carlo; Rossi, Simone; Malentacchi, Maria; Ceravolo, Roberto; Frosini, Daniela; Sestini, Stelvio; Bovi, Tommaso; Barbui, Corrado.

In: Schizophrenia Research, Vol. 139, No. 1-3, 08.2012, p. 40-45.

Research output: Contribution to journalArticle

Tinazzi, M, Cipriani, A, Matinella, A, Cannas, A, Solla, P, Nicoletti, A, Zappia, M, Morgante, L, Morgante, F, Pacchetti, C, Sciarretta, M, Dallocchio, C, Rossi, S, Malentacchi, M, Ceravolo, R, Frosini, D, Sestini, S, Bovi, T & Barbui, C 2012, '[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism', Schizophrenia Research, vol. 139, no. 1-3, pp. 40-45. https://doi.org/10.1016/j.schres.2012.06.003
Tinazzi, Michele ; Cipriani, Andrea ; Matinella, Angela ; Cannas, Antonino ; Solla, Paolo ; Nicoletti, Alessandra ; Zappia, Mario ; Morgante, Letterio ; Morgante, Francesca ; Pacchetti, Claudio ; Sciarretta, Massimo ; Dallocchio, Carlo ; Rossi, Simone ; Malentacchi, Maria ; Ceravolo, Roberto ; Frosini, Daniela ; Sestini, Stelvio ; Bovi, Tommaso ; Barbui, Corrado. / [123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. In: Schizophrenia Research. 2012 ; Vol. 139, No. 1-3. pp. 40-45.
@article{3e0ba3b9fe10442fbb2464fb53461f5f,
title = "[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism",
abstract = "Drug-induced parkinsonism (DIP) in patients treated with antipsychotic drugs is considered a form of post-synaptic parkinsonism, caused by D2-receptor blockade. Recent studies, however, carried out on small and heterogeneous patient samples, have shown that DIP may be associated with [123I]FP-CIT single photon emission computed tomography (SPECT) abnormalities, which are markers of dopamine nigrostriatal terminal defect.In the present study, outpatients fulfilling the DSM-IV criteria for schizophrenia and treated with antipsychotics for at least 6months, were enrolled in order to estimate the prevalence of DIP and, among patients with DIP, the prevalence of [123I]FP-CIT SPECT abnormalities. Socio-demographic and clinical variables associated with the presence of DIP and SPECT abnormalities were also assessed.DIP was diagnosed in 149 out of 448 patients with schizophrenia (33{\%}). Age, use of long-acting antipsychotics and a positive family history of parkinsonism were the only demographic variables significantly associated with the development of DIP. Neuroimaging abnormalities were found in 41 of 97 patients who agreed to undergo [123I]FP-CIT SPECT (42{\%}). Only age differentiated this group of patients from those with normal imaging.These preliminary findings suggest that D2-receptor blockade may coexist with a dopamine nigrostriatal terminal defect, as assessed by [123I]FP-CIT SPECT abnormalities, in a relevant proportion of DIP patients. Longitudinal studies should be designed with the aim of improving our understanding of the mechanisms of pre-synaptic abnormalities in DIP patients and identifying specific treatment strategies.",
keywords = "[I]FP-CIT SPECT, Antipsychotics, Dopamine receptors, Parkinsonism, Schizophrenia",
author = "Michele Tinazzi and Andrea Cipriani and Angela Matinella and Antonino Cannas and Paolo Solla and Alessandra Nicoletti and Mario Zappia and Letterio Morgante and Francesca Morgante and Claudio Pacchetti and Massimo Sciarretta and Carlo Dallocchio and Simone Rossi and Maria Malentacchi and Roberto Ceravolo and Daniela Frosini and Stelvio Sestini and Tommaso Bovi and Corrado Barbui",
year = "2012",
month = "8",
doi = "10.1016/j.schres.2012.06.003",
language = "English",
volume = "139",
pages = "40--45",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier B.V.",
number = "1-3",

}

TY - JOUR

T1 - [123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism

AU - Tinazzi, Michele

AU - Cipriani, Andrea

AU - Matinella, Angela

AU - Cannas, Antonino

AU - Solla, Paolo

AU - Nicoletti, Alessandra

AU - Zappia, Mario

AU - Morgante, Letterio

AU - Morgante, Francesca

AU - Pacchetti, Claudio

AU - Sciarretta, Massimo

AU - Dallocchio, Carlo

AU - Rossi, Simone

AU - Malentacchi, Maria

AU - Ceravolo, Roberto

AU - Frosini, Daniela

AU - Sestini, Stelvio

AU - Bovi, Tommaso

AU - Barbui, Corrado

PY - 2012/8

Y1 - 2012/8

N2 - Drug-induced parkinsonism (DIP) in patients treated with antipsychotic drugs is considered a form of post-synaptic parkinsonism, caused by D2-receptor blockade. Recent studies, however, carried out on small and heterogeneous patient samples, have shown that DIP may be associated with [123I]FP-CIT single photon emission computed tomography (SPECT) abnormalities, which are markers of dopamine nigrostriatal terminal defect.In the present study, outpatients fulfilling the DSM-IV criteria for schizophrenia and treated with antipsychotics for at least 6months, were enrolled in order to estimate the prevalence of DIP and, among patients with DIP, the prevalence of [123I]FP-CIT SPECT abnormalities. Socio-demographic and clinical variables associated with the presence of DIP and SPECT abnormalities were also assessed.DIP was diagnosed in 149 out of 448 patients with schizophrenia (33%). Age, use of long-acting antipsychotics and a positive family history of parkinsonism were the only demographic variables significantly associated with the development of DIP. Neuroimaging abnormalities were found in 41 of 97 patients who agreed to undergo [123I]FP-CIT SPECT (42%). Only age differentiated this group of patients from those with normal imaging.These preliminary findings suggest that D2-receptor blockade may coexist with a dopamine nigrostriatal terminal defect, as assessed by [123I]FP-CIT SPECT abnormalities, in a relevant proportion of DIP patients. Longitudinal studies should be designed with the aim of improving our understanding of the mechanisms of pre-synaptic abnormalities in DIP patients and identifying specific treatment strategies.

AB - Drug-induced parkinsonism (DIP) in patients treated with antipsychotic drugs is considered a form of post-synaptic parkinsonism, caused by D2-receptor blockade. Recent studies, however, carried out on small and heterogeneous patient samples, have shown that DIP may be associated with [123I]FP-CIT single photon emission computed tomography (SPECT) abnormalities, which are markers of dopamine nigrostriatal terminal defect.In the present study, outpatients fulfilling the DSM-IV criteria for schizophrenia and treated with antipsychotics for at least 6months, were enrolled in order to estimate the prevalence of DIP and, among patients with DIP, the prevalence of [123I]FP-CIT SPECT abnormalities. Socio-demographic and clinical variables associated with the presence of DIP and SPECT abnormalities were also assessed.DIP was diagnosed in 149 out of 448 patients with schizophrenia (33%). Age, use of long-acting antipsychotics and a positive family history of parkinsonism were the only demographic variables significantly associated with the development of DIP. Neuroimaging abnormalities were found in 41 of 97 patients who agreed to undergo [123I]FP-CIT SPECT (42%). Only age differentiated this group of patients from those with normal imaging.These preliminary findings suggest that D2-receptor blockade may coexist with a dopamine nigrostriatal terminal defect, as assessed by [123I]FP-CIT SPECT abnormalities, in a relevant proportion of DIP patients. Longitudinal studies should be designed with the aim of improving our understanding of the mechanisms of pre-synaptic abnormalities in DIP patients and identifying specific treatment strategies.

KW - [I]FP-CIT SPECT

KW - Antipsychotics

KW - Dopamine receptors

KW - Parkinsonism

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84863781344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863781344&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2012.06.003

DO - 10.1016/j.schres.2012.06.003

M3 - Article

VL - 139

SP - 40

EP - 45

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -